Erysipelas after surgery for breast cancer: a real-world cohort

Erysipelas is often related to lymphedema, which can occur in up to 60% of cases, with advanced age, radiotherapy, tumor extension, surgical approach, and infections as risk factors. The aim of this study was to present and discuss a series of cases of erysipelas after breast cancer surgery treated in a private mastology clinic over the past ten years. This is a retrospective horizontal cohort study in which we selected all cases of erysipelas after breast cancer surgery from 2009 to 2019. The following were evaluated: number of patients treated with a diagnosis of breast carcinoma with axillary approach, age, surgery performed, adjuvant treatment and treatment of erysipelas, presence of lymphedema, and measurement of circumferences between both arms and associated diseases. A total of 12 cases of breast cancer were treated. In 66.66% of cases, a radical axillary lymphadenectomy was performed, and in 16.66% of cases, only a sentinel lymph node investigation was performed. The average age was 67.6 years. Erysipelas appeared, on average, 43 months after cancer diagnosis. Two deaths were reported due to severe erysipelas leading to sepsis. More studies are still needed on the subject. Of the 12 cases in this study, eight (66.66%) were associated with lymphedema. Only two (16.66%) of the patients in this group who developed erysipelas were not submitted to axillary dissection. The treatment for 50% of the participants in this research was with penicillin G benzathine. There were three relapses, and two patients died during the research period

Hepatic vein migration of a totally implantable venous access port-a-cath for chemotherapy in a breast carcinoma patient: case report.

A totally implantable venous access port (TIVAP) is used for chemotherapy administration. Venous port migration to the systemic circulation occurs in less than 1% of complications. The aim of this study is to describe a case of TIVAP migration to the hepatic vein. A 44-year-old female patient with breast cancer was prescribed neoadjuvant chemotherapy. A port-a-cath was surgically implanted for chemotherapy. During the port puncture procedure, blood returned normally when aspirated. When the port was first accessed and flushed with saline solution, swelling was observed at the port site and blood could no longer be aspirated. A chest radiography showed catheter embolization in the region of the hepatic vein. The catheter was retrieved using a snare technique (without complications) and the patient was discharged the next day. The care team should be alert to possible TIIVAP malfunction.

Leiomyoma of the Vulva: Case Report.

BACKGROUND: Leiomyoma of the vulva is rare, accounting for only 0.03% of all gynecological tumors, and it is seldom seen in teenagers. CASE: We describe a case of vulvar leiomyoma in a 14-year-old girl who presented a 10 × 10 cm solid tumor in the right hemivulva without other complaints. SUMMARY AND CONCLUSION: Differential diagnosis includes Bartholin cysts, abscesses, fibromas, and other solid lesions. Although rare, vaginal leiomyoma must be remembered and included as a differential diagnosis for solid lesions in the vagina.

Migração para veia hepática de cateter totalmente implantável para quimioterapia em paciente com carcinoma de mama: relato de caso / Hepatic vein migration of a totally implantable venous access port-a-cath for chemotherapy in a breast carcinoma patient: case report

Resumo O cateter totalmente implantável (CTI) é utilizado na administração da quimioterapia. Em menos de 1% dos casos de complicação, pode ocorrer migração do CTI para quimioterapia para a circulação sistêmica. O objetivo deste estudo foi descrever um caso de migração do CTI para a veia hepática. Uma paciente do sexo feminino, de 44 anos de idade, teve diagnóstico de câncer de mama com indicação de quimioterapia neoadjuvante. Realizou-se a implantação de cateter port-a-cath. Durante o procedimento de punção do cateter, houve retorno normal de sangue, e foi realizada infusão de soro fisiológico. Em seguida, houve um aumento de volume no local do port e não retorno de sangue à aspiração. A radiografia de tórax mostrou embolização do cateter em topografia hepática. Retirou-se o cateter pela técnica do laço (sem complicações), e a paciente recebeu alta no dia seguinte. Possíveis alterações no funcionamento do CTI devem chamar atenção da equipe responsável.

Abstract A totally implantable venous access port (TIVAP) is used for chemotherapy administration. Venous port migration to the systemic circulation occurs in less than 1% of complications. The aim of this study is to describe a case of TIVAP migration to the hepatic vein. A 44-year-old female patient with breast cancer was prescribed neoadjuvant chemotherapy. A port-a-cath was surgically implanted for chemotherapy. During the port puncture procedure, blood returned normally when aspirated. When the port was first accessed and flushed with saline solution, swelling was observed at the port site and blood could no longer be aspirated. A chest radiography showed catheter embolization in the region of the hepatic vein. The catheter was retrieved using a snare technique (without complications) and the patient was discharged the next day. The care team should be alert to possible TIIVAP malfunction.

Mesotelioma epitelioide multicístico infiltrando parede abdominal e coxa: relato de caso / Multicystic epithelioid mesothelioma infiltrating abdominal wall and thigh: case report

RESUMO O mesotelioma epitelioide multicístico é um tumor benigno raro que surge a partir de modificações nas células mesoteliais peritoneais. Relatamos um caso de um grande mesotelioma epitelioide multicístico em paciente do sexo feminino com infiltração em parede abdominal e coxa. Foi realizada a ressecção ampla do tumor e reconstrução com múltiplos retalhos fasciocutâneos randomizados em região do abdome, flancos, retalhos de coxa direita e esquerda e retalho de vulva. Segue há 9 meses com cicatrização completa sem recidiva e sem queixas.

Abstract Multicystic epithelioid mesothelioma is a rare benign tumor that arises from changes in peritoneal mesothelial cells. We report a large multicystic epithelioid mesothelioma case in a female patient with infiltration into the abdominal wall and thigh. Extensive tumor resection and reconstruction were performed with multiple fasciocutaneous flaps randomized in the abdominal region, flanks, right and left thigh flaps and vulva flap. It has been in full healing for nine months without recurrence and complaints.

Úlcera de Marjolin em cicatriz de lesão por pressão: relato de caso / Marjolin ulcer in pressure injury scar: a case report

A úlcera de Marjolin (carcinoma epidermoide) é uma condição rara que surge de uma lesão cutânea crônica. Apresentamos o caso de uma paciente que desenvolveu um carcinoma epidermoide em tecido cicatricial de uma úlcera por pressão. Depois de onze anos da cirurgia para corrigir uma úlcera por pressão no glúteo direito, a paciente desenvolveu um carcinoma epidermoide numa úlcera por pressão no glúteo esquerdo e negligenciou a afecção. Realizou-se ampla ressecção da lesão com margens livres no resultado histopatológico final. Úlcera de Marjolin é uma expressão que comumente se refere à degeneração maligna de feridas crônicas que não curaram ou curaram por segunda intenção. Com frequência se descreve como vários tipos de lesiones, incluídas as cicatrizes das úlceras por pressão. Os mecanismos patogênicos por trás da transformação maligna destas lesões ainda não foram dilucidados por completo. O diagnóstico se realiza inicialmente mediante exame clínico devido ao aspecto da lesão e se confirma por biópsia. A cirurgia é o tratamento de eleição com o fechamento do defeito com retalhos ou enxertos, dependendo de cada caso.

Marjolin ulcer (epidermoid carcinoma) is a rare condition that arises from a chronic skin lesion. We present a patient who developed an epidermoid carcinoma in the scar tissue of a pressure ulcer. After eleven years of surgery to correct a pressure ulcer in the right gluteus, the patient developed an epidermoid carcinoma in a pressure ulcer in the left gluteus and neglected the condition. Wide resection of the lesion was performed with free margins in the final histopathological result. Marjolin ulcer is an expression that commonly refers to the malignant degeneration of chronic wounds that have not healed or healed by secondary intention. It is often described as various types of lesions, including the scars of pressure ulcers. The pathogenic mechanisms behind the malignant transformation of these lesions have not yet been completely elucidated. The diagnosis is initially made by clinical examination due to the lesion aspect and is confirmed by biopsy. Surgery is the choice treatment closing the defect with flaps or grafts, depending on each case.

Opinião de médicos brasileiros sobre o tratamento da COVID-19 / Opinion of Brazilian physicians on the treatment of COVID-19 / Opinión de médicos brasileños sobre el tratamiento de la COVID-19

Objetivo: Investigar a opinião de médicos brasileiros sobre o tratamento precoce da COVID-19 com hidroxicloroquina/ cloroquina e azitromicina em pacientes com suspeita clínica e sobre o tratamento com corticoterapia na fase inflamatória da doença. Métodos: Trata-se de uma pesquisa de opinião, com amostragem por conveniência, com médicos atuantes no Brasil. A coleta dos dados ocorreu no período de 26 de maio a 8 de junho de 2020 (13 dias), por meio de um formulário Google, disponibilizado publicamente nas redes sociais e aplicativos de comunicação. Realizou-se uma análise descritiva dos dados, teste de independência, teste T Student e modelo de regressão logística com análise multivariada. Resultados: A pesquisa contou com 1.020 médicos participantes, com média de 21,9 anos de formado. 72,4% dos participantes apresentaram-se a favor do tratamento precoce com hidroxicloroquina/cloroquina e azitromicina e 89,7% dos médicos apresentaram-se favoráveis ao uso da corticoterapia para o tratamento da fase inflamatória da COVID-19. Constatou-se também que participantes com maior idade, com residência médica, atuantes nas regiões Nordeste e Norte possuíam mais chances de serem favoráveis aos tratamentos. Por outro lado, profissionais especialistas em medicina intensiva, infectologia e pneumologia, além de atuantes nas unidades de terapia intensiva, mostraram-se mais desfavoráveis. Conclusão: A maioria dos médicos investigados nesta pesquisa de opinião mostrou-se a favor do tratamento precoce apresentado e do uso da corticoterapia no tratamento da COVID-19. Já os especialistas em medicina intensiva, infectologia e pneumologia e profissionais atuantes nas Unidades de Terapia Intensiva mostraram-se mais desfavoráveis.

Objective: To investigate the opinion of Brazilian physicians on the early treatment of COVID-19 with hydroxychloroquine/ chloroquine and azithromycin in patients with clinical suspicion and on the treatment with corticosteroid therapy in the inflammatory stage of the disease. Methods: This is an opinion survey conducted with a convenient sample of physicians working in Brazil. Data were collected from May 26 to June 8, 2020 (13 days) through Google forms made publicly available on social media and chat applications. Data underwent descriptive analysis, independence test, Student t-test, and a logistic regression model using multivariate analysis. Results: The survey included 1020 physicians with a mean of 21.9 years since graduation. 72.4% of the participants were in favor of early treatment with hydroxychloroquine/chloroquine and azithromycin and 89.7% of the physicians were in favor of using corticosteroid therapy to treat the inflammatory stage of COVID-19. We also observed that older participants, those who completed medical residency, and those working in the Northeast and North regions were more likely to be in favor of the treatments. On the other hand, professionals specialized in intensive care medicine, infectious diseases and pneumology and working in intensive care units were more opposed. Conclusion: Most physicians in this opinion survey were in favor of the early treatment presented and the use of corticosteroid therapy in the treatment of COVID-19. But specialists in intensive care medicine, infectious diseases and pulmonology, and professionals working in Intensive Care Units were more opposed to them.

Objetivo: Investigar la opinión de médicos brasileños sobre el tratamiento precoz de la COVID-19 con la hidroxicloroquina/ cloroquina y la azitromicina en pacientes con sospecha clínica y bajo el tratamiento de corticoterapia en la fase inflamatoria de la enfermedad. Métodos: Se trata de una investigación de opinión con la muestra de conveniencia realizada con médicos de Brasil. La recogida de datos se dio en el periodo entre 26 de mayo y 8 de junio de 2020 (13 días) a través de un formulario Google que ha estado disponible públicamente en las redes sociales y los aplicativos de comunicación. Se realizó un análisis descriptivo de los datos, la prueba de independencia, la prueba T Student y el modelo de regresión logística con el análisis multivariado. Resultados: La investigación tuvo 1.020 médicos participantes, con la media de 21,9 años de término del grado. El 72,4% de los participantes se presentaron a favor del tratamiento precoz con la hidroxicloroquina/cloroquina y la azitromicina y el 89,7% de los médicos se presentaron favorables a la utilización de la corticoterapia para el tratamiento de la fase inflamatoria de la COVID-19. Se constató también que los participantes de más edad, con el curso de residencia medica y que eran de las regiones Noreste y Norte del país eran más favorables a los tratamientos. Los profesionales especialistas de la medicina intensiva, la infectologia y la neumología, además de actuaren en las unidades de cuidados intensivos parecieron más desfavorables. Conclusión: La mayoría de los médicos investigados de esa investigación de opinión se mostró favorable al tratamiento precoz presentado y a la utilización de la corticoterapia para el tratamiento de la COVID-19. Los especialistas de la medicina intensiva, la infectología y la neumología y los profesionales de las Unidades de Cuidados Intensivos se presentaron más desfavorables a los tratamientos.

Low-grade carcinoma in situ in fibroadenoma: a case report

Fibroadenomas are the most common benign breast neoplasms. In rare cases, a carcinoma may develop within a fibroadenoma. The aim of this study was to report a case of low-grade carcinoma in situ in a fibroadenoma. A 31-year-old female, G0P0A0 and without family history of cancer, arrives at the service with an expressive breast lump growth along the year year. Core biopsy, histopathological and immunohistochemical studies showed an in-situ carcinoma in a fibroadenoma. Surgical resection was performed with a safety margin, and anatomopathological study and immunohistochemistry of the surgical specimen confirmed the core biopsy diagnosis. Currently, the patient is under annual clinical follow-up with mammography and breast ultrasound and no evidence of neoplastic disease. Although this is a rare event and few cases are described in the literature, carcinomas in situ can occur in a fibroadenoma.

Radiation-induced angiosarcoma: case report.

Angiosarcoma of the breast accounts for less than 1% of breast tumors. This tumor may be primary or secondary to previous radiation therapy and it is also named "radiogenic angiosarcoma of the breast", which is still a rare entity with a poor prognosis. So far, there are only 307 cases reported about these tumors in the literature. We present a case of a 73-year-old woman with a prior history of breast-conserving treatment of right breast cancer, exhibiting mild pinkish skin changes in the ipsilateral breast. Her mammography was consistent with benign alterations (BI-RADS 2). On incisional biopsy specimens, hematoxylin-eosin showed atypical vascular lesion and suggested immunohistochemisty for diagnostic elucidation. Resection of the lesions was performed and histology showed radiogenic angiosarcoma. The patient underwent simple mastectomy. Immunohistochemistry was positive for antigens related to CD31 and CD34, and C-MYC oncogene amplification, confirming the diagnosis of angiosarcoma induced by breast irradiation. A delayed diagnosis is an important concern. Initial skin changes in radiogenic angiosarcoma are subtle, therefore, these alterations may be confused with other benign skin conditions such as telangiectasia. We highlight this case clinical aspects with the intention of alerting to the possibility of angiosarcoma of the breast in patients with a previous history of adjuvant radiation therapy for breast cancer treatment. Sixteen months after the surgery the patient remains asymptomatic.

Avaliação da prevalência de anemia pós-parto e fatores associados em uma maternidade terciária do estado do Piauí / Prevalence of postpartum anemia and associated factors in a tertiary maternity hospital of the state of Piaui

Este trabalho avaliou a prevalência de anemia puerperal por meio das dosagens de hemoglobina (Hb) e hematócrito (Ht) numa maternidade pública terciária do estado do Piauí e os fatores de risco associados à presença de anemia. No total, 198 puérperas internadas na maternidade foram submetidas a entrevista e análise do prontuário e do cartão pré-natal. Foram feitas coletas de amostra de sangue venoso periférico antes do parto, 24 horas após o parto vaginal e 48 horas após o parto cesariano. A prevalência de anemia pós-parto encontrada na maternidade estudada foi de 27,27%. A presença de anemia pré-parto e gemelaridade e o ganho de peso foram os fatores de risco significativamente associados à anemia pós-parto.(AU)

This study evaluated the prevalence of puerperal anemia using hemoglobin (Hb) and hematocrit (Ht) measurements in a public tertiary maternity hospital in the state of Piauí and the risk factors associated with the presence of anemia. In total, 198 puerperal women admitted to the maternity hospital were interviewed, analyzed the medical record and the prenatal card. A peripheral venous blood sample was collected before delivery, 24 hours after vaginal delivery and 48 hours after cesarean delivery. The prevalence of postpartum anemia found in the maternity studied was 27.27%. The presence of pre-delivery anemia, twinning and weight gain were the risk factors significantly associated with postpartum anemia.(AU)

Tratamento precoce para COVID-19 baseado em evidência científica / Early treatment of COVID-19 based on scientific evidence / Tratamiento precoz para COVID-19 basado en evidencia científica

Objetivo: Apresentar uma proposta de tratamento precoce para pacientes com COVID-19 em Unidade Básica de Saúde (UBS). Métodos: Trata-se de uma proposta de protocolo de tratamento para COVID-19 com hidroxicloroquina ou cloroquina com base na literatura científica disponível no momento (13 de junho de 2020). O levantamento dos estudos ocorreu na base PubMed, por meio dos descritores COVID-19, hydroxychloroquine e chloroquine. Foram selecionados cinco artigos, dos 645 artigos encontrados, por abordarem o uso de hidroxicloroquina ou cloroquina no tratamento da fase precoce da COVID-19. Resultados: A proposta de protocolo para tratamento precoce para pacientes com suspeita de COVID-19 envolve orientações sobre os principais sintomas, orientações gerais à população, avaliação médica, considerações sobre exames, terapia recomendada, orientações pós prescrição e critérios para internação. Conclusão: Baseado em estudos, o tratamento precoce ambulatorial da COVID-19 com hidroxicloroquina ou cloroquina parece diminuir o risco de internação e, assim, a necessidade de leitos de terapia intensiva. A decisão de adoção do tratamento a ser proposto é do paciente, e o médico só deve adotar após o paciente assinar o consentimento livre e esclarecido, por tratar-se de prescrição off label. Estudos randomizados são necessários para confirmar essa hipótese.

Objective: To present a proposal for early treatment of patients with COVID-19 in a Primary Health Care (PHC) center. Methods: This is a proposed treatment protocol for COVID-19 using hydroxychloroquine or chloroquine based on the currently (June 13, 2020) available scientific literature. PubMed database was searched for studies using the descriptors COVID-19, hydroxychloroquine, and chloroquine. Five studies were selected from the 645 studies found as they addressed the use of hydroxychloroquine or chloroquine in the treatment of COVID-19 in early stages. Results: The proposed early treatment protocol for patients with suspected COVID-19 includes guidance on the main symptoms, general guidelines for the population, medical evaluation, examination considerations, recommended therapy, post-prescription guidelines and criteria for hospitalization. Conclusion: According to the studies, early outpatient treatment of COVID-19 with hydroxychloroquine or chloroquine seems to decrease the risk of hospitalization and the need for intensive care beds. The decision to adopt the proposed treatment is made by the patient, and the physician should only conduct the treatment after obtaining written informed consent from the patient, as it is an off-label prescription. Randomized studies are needed to confirm this hypothesis.

Objetivo: Presentar una propuesta de tratamiento precoz para pacientes con la COVID-19 en Unidad Básica de Salud (UBS). Métodos: Se trata de una propuesta de protocolo de tratamiento para la COVID-19 con hidrocloroquina o cloroquina basado en la literatura científica disponible en el momento (13 de junio de 2020). La recogida de los estudios se dio en la base de datos PubMed a través de los descriptores COVID-19, hydroxychloroquine y chloroquine. De los 645 artículos encontrados se ha elegido cinco de ellos sobre el uso de la hidrocloroquina o cloroquina para el tratamiento de la fase precoz de la COVID-19. Resultados: En la propuesta del protocolo para el tratamiento precoz de pacientes con sospecha de la COVID-19 hay orientaciones de los síntomas principales, las orientaciones generales para la población, la evaluación médica, las consideraciones de las pruebas, la terapia recomendada, las orientaciones post prescripición y los criterios para el ingreso hospitalario. Conclusión: Basados en estudios, el tratamiento precoz de ambulatorio de la COVID-19 con hidrocloroquina o cloroquina parece disminuir el riesgo de ingreso hospitalario y la necesidad de camas de la unidad de cuidados intensivos. La decisión para la adhesión al tratamiento propuesto es del paciente y el medico solo debe iniciarlo tras la firma del consentimiento libre esclarecido de parte del paciente una vez que se trata de prescripción off label. Son necesarios estudios randomizados para confirmar esa hipótesis.

Radiation-induced angiosarcoma: case report / Angiossarcoma induzido por radiação: relato de caso

ABSTRACT Angiosarcoma of the breast accounts for less than 1% of breast tumors. This tumor may be primary or secondary to previous radiation therapy and it is also named "radiogenic angiosarcoma of the breast", which is still a rare entity with a poor prognosis. So far, there are only 307 cases reported about these tumors in the literature. We present a case of a 73-year-old woman with a prior history of breast-conserving treatment of right breast cancer, exhibiting mild pinkish skin changes in the ipsilateral breast. Her mammography was consistent with benign alterations (BI-RADS 2). On incisional biopsy specimens, hematoxylin-eosin showed atypical vascular lesion and suggested immunohistochemisty for diagnostic elucidation. Resection of the lesions was performed and histology showed radiogenic angiosarcoma. The patient underwent simple mastectomy. Immunohistochemistry was positive for antigens related to CD31 and CD34, and C-MYC oncogene amplification, confirming the diagnosis of angiosarcoma induced by breast irradiation. A delayed diagnosis is an important concern. Initial skin changes in radiogenic angiosarcoma are subtle, therefore, these alterations may be confused with other benign skin conditions such as telangiectasia. We highlight this case clinical aspects with the intention of alerting to the possibility of angiosarcoma of the breast in patients with a previous history of adjuvant radiation therapy for breast cancer treatment. Sixteen months after the surgery the patient remains asymptomatic.

RESUMO Os angiossarcomas de mama representam menos de 1% dos tumores da mama e podem ser primários ou secundários à radioterapia prévia. Tais tumores são chamados de "angiossarcomas radiogênicos da mama" e representam uma entidade mais rara ainda e de prognóstico ruim. Atualmente, na literatura, são encontrados apenas 307 casos desses tumores. Relatamos o caso de uma mulher de 73 anos, com história prévia de tratamento conservador de câncer de mama direita, apresentando alteração rósea discreta em pele da mama homolateral. A mamografia demostrou resultado compatível com alterações benignas (BI-RADS 2). No material de biópsia incisional, a hematoxilina-eosina demonstrou lesão vascular atípica e sugeriu imuno-histoquímica para elucidação diagnóstica. A paciente foi submetida à ressecção de lesões, e a histologia demonstrou angiossarcoma radiogênico. Em seguida, mastectomia simples foi realizada. A imuno-histoquímica demonstrou positividade para os antígenos relacionados a CD31 e CD34, e a amplificação do oncogene C-MYC confirmou o diagnóstico de angiossarcoma induzido por radiação mamária. O atraso no diagnóstico constitui questão importante. Considerando que as alterações iniciais da pele do angiossarcoma radiogênico são sutis e podem ser confundidas com outras condições benignas da pele, como telangiectasias, neste relato destacamos os aspectos clínicos, no intuito de alertar sobre a possibilidade de angiossarcoma de mama em pacientes com história prévia de radioterapia adjuvante para tratamento de câncer de mama. A paciente permaneceu assintomática 16 meses após a cirurgia.

Breast cancer after chest irradiation for lymphoma: case report

Breast cancer is one of the most common diseases among women worldwide. One of the risk factors for the development of this neoplasia is previous radiotherapy on the chest wall. Breast cancer, in turn, is the main long-term concern among women treated for lymphoma with radiation on the chest wall. Thus, we present a case of breast cancer that appeared 18 years after chest radiation for the treatment of lymphoma.

Idiopathic granulomatous mastitis: case series / Mastite granulomatosa idiopática: série de casos

Idiopathic granulomatous mastitis is a rare disease that mimics other pathological conditions, including breast adenocarcinoma, breast tuberculosis, and abscess. Three patients diagnosed with idiopathic granulomatous mastitis were analyzed, receiving corticosteroid treatment, antibiotic therapy in cases of abscesses, and, in one case, resection of the affected breast segment. All patients exhibited regression of symptoms.

A mastite granulomatosa idiopática é uma doença rara que mimetiza outras condições patológicas, incluindo adenocarcinoma de mama, tuberculose de mama e abscesso. Foram analisados três pacientes com diagnóstico de mastite granulomatosa idiopática, que receberam como tratamento corticosteroide, antibioticoterapia em casos de abscessos e, em um caso, ressecção do segmento mamário afetado. Todas as pacientes evoluíram com regressão dos sintomas.

Retalho toracoabdominal para reconstrução de tumor de mama localmente avançado, em paciente com mutação de BRCA1 / Thoracoabdominal flap for locally advanced breast tumor reconstruction in a patient with BRCA1 mutation

O presente estudo objetiva relatar a técnica do retalho toracoabdominal pós-mastectomia por tumor localmente avançado em paciente com mutação de BRCA1. Foi realizada a mastectomia com ressecção de quase todo o músculo peitoral maior à esquerda, com linfonodectomia axilar homolateral e reconstrução do grande defeito da parede torácica com retalho toracoabdominal fasciocutâneo, baseado nas artérias intercostais posteriores.

This case report describes the application of the thoracoabdominal flap technique after locally advanced tumor mastectomy in a patient with breast cancer 1 (BRCA1) mutation. The mastectomy included resection of nearly the entire left pectoralis major muscle, with homolateral axillary lymphadenectomy and reconstruction of the large chest wall defect with a fasciocutaneous thoracoabdominal flap based on the posterior intercostal arteries.

Fatores determinantes para a ocorrência de acidentes domésticos na primeira infância / Determining factors of domestic accidents in early childhood

INTRODUCTION: Domestic accidents are one of the main causes of death among children, characterized by an event that involves multiple determinants, emphasizing, among others, intrapersonal, interpersonal, cultural and institutional factors. OBJECTIVE: To analyse the determinants of domestic accidents in early childhood. METHODS: This is an exploratory, descriptive, and cross-sectional study carried out in the Emergency Hospital of Teresina city, Piauí, Brazil, between January and March 2016. The population was composed of 21 caregivers of children under five years old, hospitalized between January and March 2016. For data collection, a structured interview was conducted on aspects related to the risk factors associated with the incidence of domestic accidents involving children. A descriptive analysis was performed, with absolute and relative frequencies for the variables. The Human Research Ethics Committee approved the research with Protocol No. 1324184. RESULTS: In relation to intrapersonal factors, pre-school children were the main victims (57.2%). For interpersonal factors, it was observed that most of participants (85.7%) considered the household unsafe for children. The evaluation of institutional factors showed that most caregivers (52.4%) had not been advised about the prevention of accidents at home. In terms of cultural factors, most participants (81%) had not heard news about domestic accidents. CONCLUSION: Parents and caregivers have very limited knowledge about the prevention of childhood accidents at home, with male pre-schoolers the main victims of domestic accidents.

INTRODUÇÃO: O acidente doméstico é uma das principais causas de morte entre crianças, caracterizando-se por ser um evento que envolve múltiplos fatores determinantes, destacando-se os fatores intrapessoais, interpessoais, culturais e institucionais. OBJETIVO: Analisar os fatores determinantes para ocorrência de acidentes domésticos na primeira infância. MÉTODO: Trata-se de um estudo exploratório e descritivo, transversal, realizado no município de Teresina-PI, no Hospital de Urgência, no período de janeiro a março de 2016. A população foi composta por 21 cuidadores de crianças menores de cinco anos internados entre janeiro a março de 2016. Para coleta de dados realizou-se uma entrevista estruturada sobre os aspectos relacionados aos fatores determinantes para ocorrência de acidentes domésticos com crianças. Realizou-se uma análise descritiva, a partir de frequências absolutas e relativas para as variáveis. Foi aprovado pelo Comitê de Ética em Pesquisa sob parecer de nº 1.324.184. RESULTADOS: Em relação aos fatores intrapessoais para ocorrência de acidentes domésticos, os pré-escolares foram as principais vítimas (57,2%). Na análise dos fatores interpessoais, averígua-se que a maioria das participantes (85,7%) não considerava o domicílio seguro para crianças. A avaliação dos fatores institucionais demonstrou que a maioria (52,4%) das cuidadoras não havia sido orientada quanto à prevenção de acidentes no domicílio. Sobre os fatores culturais, a maioria das participantes (81%) não havia tido conhecimento de notícias sobre acidentes domésticos. CONCLUSÃO: O pré-escolar do sexo masculino é a principal vítima de acidentes domésticos e são incipientes as orientações de pais e cuidadores sobre a prevenção de acidentes na infância.